Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription

Articles published in Nat Med

Retrieve available abstracts of 12 articles:
HTML format
Text format

Single Articles

    January 2018
  1. BOSHUIZEN J, Koopman LA, Krijgsman O, Shahrabi A, et al
    Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.
    Nat Med. 2018 Jan 15. pii: nm.4472. doi: 10.1038/nm.4472.
    PubMed     Text format     Abstract available

    October 2017
  2. MURGAI M, Ju W, Eason M, Kline J, et al
    KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis.
    Nat Med. 2017;23:1176-1190.
    PubMed     Text format     Abstract available

    August 2017
  3. XUE Y, Martelotto L, Baslan T, Vides A, et al
    An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
    Nat Med. 2017;23:929-937.
    PubMed     Text format     Abstract available

    July 2017
  4. MAYORCA-GUILIANI AE, Madsen CD, Cox TR, Horton ER, et al
    ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix.
    Nat Med. 2017;23:890-898.
    PubMed     Text format     Abstract available

    December 2016
  5. PEINADO H, Alec kovic M, Lavotshkin S, Matei I, et al
    Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
    Nat Med. 2016;22:1502.
    PubMed     Text format    

    October 2016
  6. LINNEMANN C, van Buuren MM, Bies L, Verdegaal EM, et al
    Corrigendum: High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
    Nat Med. 2016;22:1192.
    PubMed     Text format    

    August 2016
  7. SHEN CH, Kim SH, Trousil S, Frederick DT, et al
    Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.
    Nat Med. 2016 Aug 8. doi: 10.1038/nm.4155.
    PubMed     Text format     Abstract available

    June 2016
  8. LAFAVE LM, Beguelin W, Koche R, Teater M, et al
    Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status".
    Nat Med. 2016;22:578-9.
    PubMed     Text format    

  9. SCHOUMACHER M, Le Corre S, Houy A, Mulugeta E, et al
    Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status.
    Nat Med. 2016;22:577-8.
    PubMed     Text format    

    February 2016
  10. GROS A, Parkhurst MR, Tran E, Pasetto A, et al
    Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
    Nat Med. 2016 Feb 22. doi: 10.1038/nm.4051.
    PubMed     Text format     Abstract available

    November 2015
  11. GAO H, Korn JM, Ferretti S, Monahan JE, et al
    High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
    Nat Med. 2015;21:1318-25.
    PubMed     Text format     Abstract available

    June 2015
  12. VIZOSO M, Ferreira HJ, Lopez-Serra P, Carmona FJ, et al
    Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.
    Nat Med. 2015 Jun 1. doi: 10.1038/nm.3863.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.